[go: up one dir, main page]

IL163836A0 - Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a - Google Patents

Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a

Info

Publication number
IL163836A0
IL163836A0 IL16383603A IL16383603A IL163836A0 IL 163836 A0 IL163836 A0 IL 163836A0 IL 16383603 A IL16383603 A IL 16383603A IL 16383603 A IL16383603 A IL 16383603A IL 163836 A0 IL163836 A0 IL 163836A0
Authority
IL
Israel
Prior art keywords
homoerythromycin
deoxo
aza
methyl
pseudopolymorph
Prior art date
Application number
IL16383603A
Other languages
English (en)
Original Assignee
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O
Publication of IL163836A0 publication Critical patent/IL163836A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Finger-Pressure Massage (AREA)
  • Instructional Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16383603A 2002-03-18 2003-03-18 Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a IL163836A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HR20020231A HRP20020231A2 (en) 2002-03-18 2002-03-18 ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US39361202P 2002-07-03 2002-07-03
US39470502P 2002-07-08 2002-07-08
PCT/IB2003/000987 WO2003077830A2 (en) 2002-03-18 2003-03-18 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives

Publications (1)

Publication Number Publication Date
IL163836A0 true IL163836A0 (en) 2005-12-18

Family

ID=28045976

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16383603A IL163836A0 (en) 2002-03-18 2003-03-18 Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a

Country Status (23)

Country Link
US (1) US7569549B2 (is)
EP (2) EP1627883A1 (is)
JP (1) JP2005529082A (is)
KR (1) KR20050002872A (is)
CN (1) CN1642966A (is)
AT (1) ATE440104T1 (is)
AU (1) AU2003215779A1 (is)
BG (1) BG108874A (is)
BR (1) BR0308644A (is)
CA (1) CA2479211A1 (is)
DE (1) DE60328872D1 (is)
EA (1) EA200401217A1 (is)
ES (1) ES2331733T3 (is)
HR (2) HRP20020231A2 (is)
IL (1) IL163836A0 (is)
IS (1) IS7449A (is)
MX (1) MXPA04009009A (is)
NO (1) NO20044341L (is)
NZ (1) NZ535477A (is)
PL (1) PL372468A1 (is)
RS (1) RS82504A (is)
TN (1) TNSN04166A1 (is)
WO (1) WO2003077830A2 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
EP1878432A1 (en) * 2003-07-24 2008-01-16 Pliva - Research and Development Ltd. Single dose fast dissolving azithromycin
WO2005009447A1 (en) * 2003-07-24 2005-02-03 Pliva - Research And Development Ltd. Single dose fast dissolving azithromycin
WO2005053656A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
EP1691786A1 (en) 2003-12-04 2006-08-23 Pfizer Products Inc. Multiparticulate compositions with improved stability
SI1691787T1 (sl) * 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
AU2004294818A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
ATE154806T1 (de) 1993-05-19 1997-07-15 Pfizer Zwischenprodukt für azithromycin
HRP940251B1 (en) 1994-04-15 1998-12-31 Stjepan Mutak Process for the preparation of azithromycin dihydrochloride
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CN1205338A (zh) 1998-05-08 1999-01-20 刘万忠 阿奇霉素水溶性盐的合成新方法及其在医药上的用途
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6245903B1 (en) 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
AU5820400A (en) * 1999-06-29 2001-01-31 Biochemie S.A. Macrolides
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
AU2928701A (en) * 2000-01-04 2001-07-16 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
AU2000270425A1 (en) * 2000-07-25 2002-02-13 Instituto De Investigacion En Quimica Aplicada S.C Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydr oxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin
WO2002015842A2 (en) * 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
EP1339730A2 (en) * 2000-11-27 2003-09-03 Biochemie S.A. Macrolide solvates
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
IL158591A0 (en) 2001-05-22 2004-05-12 Pfizer Prod Inc Crystal forms of azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
AU2002348884A1 (en) 2001-12-21 2003-07-09 Pfizer Products Inc. Directly compressible formulations of azithromycin
WO2003053399A2 (en) 2001-12-21 2003-07-03 Pfizer Products Inc. Methods for wet granulating azithromycin
CN1646104A (zh) 2002-02-01 2005-07-27 辉瑞产品公司 阿齐霉素的干颗粒制剂
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza

Also Published As

Publication number Publication date
PL372468A1 (en) 2005-07-25
NO20044341L (no) 2004-11-23
TNSN04166A1 (en) 2007-03-12
CA2479211A1 (en) 2003-09-25
BR0308644A (pt) 2005-01-25
EP1485393A2 (en) 2004-12-15
EP1485393B1 (en) 2009-08-19
BG108874A (en) 2005-12-30
KR20050002872A (ko) 2005-01-10
IS7449A (is) 2004-09-16
EP1627883A1 (en) 2006-02-22
US20040014951A1 (en) 2004-01-22
HRP20040858A2 (en) 2005-06-30
JP2005529082A (ja) 2005-09-29
AU2003215779A1 (en) 2003-09-29
NZ535477A (en) 2006-11-30
HRP20020231A2 (en) 2003-12-31
DE60328872D1 (en) 2009-10-01
ES2331733T3 (es) 2010-01-14
RS82504A (sr) 2006-12-15
ATE440104T1 (de) 2009-09-15
US7569549B2 (en) 2009-08-04
WO2003077830A2 (en) 2003-09-25
EA200401217A1 (ru) 2005-02-24
WO2003077830A3 (en) 2004-05-13
CN1642966A (zh) 2005-07-20
MXPA04009009A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
IL163836A0 (en) Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a
BR0014274A (pt) Composições de intercalação de catodo, métodos de produção e baterias de lìtio recarregáveis contendo as mesmas
WO2003010138A3 (en) Piperidine derivatives as antibacterial agents
CA2391659A1 (en) Crystal forms of azithromycin
NO2012012I2 (no) Pasireotide (som diaspartat salt). Det kjemiske navnet er cyclo[(4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L-phenylalanyl-)
HK1056114A1 (zh) 血子板减少模仿剂
SG125957A1 (en) Composition for removing residues from the microstructure of an object
IL158485A (en) Spiropyrazole compounds
MXPA03002911A (es) Compuestos quimicos.
CA2327679A1 (en) Triphendioxazine dyestuffs for dyeing organic substrates
HK1052170A1 (zh) 新型化合物抑制因子xa活度
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
CA2395204A1 (en) Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
WO2005020293A3 (en) Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene
AU6394600A (en) Ink compositions having modified pigments with high or low treatment levels
MXPA04006041A (es) Antivirales de piridoquinoxalina.
SE9904765D0 (sv) Pharmaceutically-useful compounds
AU2002308000A1 (en) Antibacterial oxazolidinones with a cyclic sulphilimine or sulphoximine
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
WO2006041631A3 (en) Novel cyclosporin alkynes and their utility as pharmaceutical agents
TW200609228A (en) Substituted n-acyl-2-aminothiazoles
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
AU2002218354A1 (en) Crosslinkable liquid silicone composition comprising a low viscosifying filler based on zirconium, use of same as fire-resistant coating
WO2003045320A3 (en) Somatostatin analog and uses thereof
EP2264049A3 (en) 1-Desamino-8-d-arginyl vasopressin analogs